Evidence map›Paper›PMID 35762637›Full record

ArticleDrug delivery2022

Green synthesized gold nanoparticles from

Junmo Zhu, Zijing Liu, Youwei Pu, Jie Xu, Sitong Zhang, Yixi Bao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug delivery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Junmo ZhuDepartment of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zijing LiuDepartment of Gastroenterology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Youwei PuDepartment of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jie XuDepartment of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Sitong ZhangDepartment of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yixi BaoDepartment of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chongqing Medical University · CNDalian Medical University · CNSecond Affiliated Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanobiotechnology, the interface between biology and nanotechnology, has recently emerged in full bloom in the medical field due to its minimal side-effects and high efficiency. To broaden the application of nanobiotechnology, we composed gold nanoparticles from the extract of

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsMetal NanoparticlesGoldGreen Chemistry TechnologyHumansParticle SizeSpectroscopy, Fourier Transform InfraredTumor Necrosis Factor-alphaGoldTumor Necrosis Factor-alphagold nanoparticlesgreen synthesisimmune functionliver cancerPseudobulbus Cremastrae seu Pleiones

Identifiers

PMID35762637
PMCPMC9246265
OpenAlexW4283694192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.